Expression of CD28, FAS, PD1, and CTLA4 molecules in the blood of women with triple‐negative breast cancer

Background Locally advanced triple‐negative breast cancer (TNBC) represents a public health problem in Brazil. Its standard treatment consists of neoadjuvant chemotherapy (NAC). Methods This was a longitudinal study with follow‐up performed between the years 2015 and 2017. Thirty women with locally...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of surgical oncology Vol. 130; no. 4; pp. 681 - 690
Main Authors:	Salgado, Marcelo Ramos Tejo, Sobral, Denise Viana, Martins, Mario R., Salgado, Eduardo Forte M. T., Salgado, Amanda Forte M. T., Silva, Kamylla Ramos da, Soares, Fernando Augusto, Torres, Leuridan C.
Format:	Journal Article
Language:	English
Published:	United States Wiley Subscription Services, Inc 01-09-2024
Subjects:	Breast cancer Chemotherapy immune system Lymphocytes neoadjuvant therapy T lymphocytes triple negative breast neoplasms T lymphocytes triple negative breast neoplasms immune system neoadjuvant therapy
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Background Locally advanced triple‐negative breast cancer (TNBC) represents a public health problem in Brazil. Its standard treatment consists of neoadjuvant chemotherapy (NAC). Methods This was a longitudinal study with follow‐up performed between the years 2015 and 2017. Thirty women with locally advanced TNBC submitted to NAC, and 30 healthy were included. Peripheral blood samples were collected before NAC (Pre‐NAC) and after NAC (Post‐NAC). Results Patients with TNBC had elevated levels of CD28+ T, FAS+ T, CTLA4+ T, PD1+ T, CD28+CD4+ T, PD1+CD4+ T and CD8+ T and PD1+ CD8+ T cells compared to controls (p < 0.05). Patients with pathological complete response (pCR) had low FAS+ T cells, FAS+CD4+ T cells, and PD1+CD8+ T cells compared to the non‐pCR (p < 0.05). Significant differences were observed in the levels of CD28+ T cells, FAS+ T and PD1+ T, CD4+ T, CD28+CD4+ T, FAS+CD4+ T, PD1+CD4+ T, CD8+ T, and PD1+CD8+ T cells between Pre‐NAC and Post‐NAC groups (p < 0.05). Conclusion Alterations in the circulating FAS+CD4+ T and PD1+CD8+ T cell levels Pre‐NAC are associated with pCR, suggesting potential predictive biomarkers of NAC response in TNBC. The largest changes in the cellular immune response profile Post‐NAC showed that chemotherapy treatment can modulate the immune response and that it is associated with prognosis in TNBC.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0022-4790 1096-9098 1096-9098
DOI:	10.1002/jso.27725